BioMimetic Therapeutics, Inc. to Highlight Corporate Activities at Upcoming Conferences.FRANKLIN, Tenn. -- BioMimetic Therapeutics, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : BMTI BMTI Block Mode Terminal Interface ) announced today that Dr. Samuel E. Lynch, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , will provide an update of corporate activities at the BIO CEO & Investor Conference 2007. The presentation will take place at the Waldorf Astoria Hotel in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. on Tuesday, February 13 at 11:15 a.m. Eastern Time. A live audio webcast of the presentation will be available at http://www.corporate-ir.net/ireye/conflobby.zhtml? ticker=BMTI&item_id=1441824 and on the Company's website at www.biomimetics bi·o·mi·met·ics n. (used with a sing. verb) The study of the structure and function of biological systems as models for the design and engineering of materials. .com. The webcast will be accessible for a period of at least 30 days. The Company also announced that Larry Bullock, chief financial officer, will highlight corporate activities at the Deutsche Bank Small Cap Growth Conference in Naples, Florida. The presentation will take place at the Ritz-Carlton Hotel on Tuesday, February 13 at 3:20 p.m. Eastern Time. The live audio webcast of the presentation will be available at http://www.corporate-ir.net/ireye/conflobby.zhtml? ticker=BMTI&item_id=1426558 and on the Company's website. (Due to their length, the above URLs may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.) In addition, the Company announced that Dr. Charles E. Hart Charles Edward Hart (June 17, 1900 - December 9, 1991) born in Fort Washington, Maryland was a Commanding General of the V Corps (1954-1956) and Commanding General of the U.S. Second Army (1957-1960). , chief scientific officer, will be presenting at the First Albany Capital 2nd Annual Orthopedic Conference on Tuesday, February 13, 2007, at 9:50 a.m. Pacific Time. The conference is being held at the Marina Village Conference Center in San Diego, California “San Diego” redirects here. For other uses, see San Diego (disambiguation). San Diego is a coastal Southern California city located in the southwestern corner of the continental United States. As of 2006, the city has a population of 1,256,951. . About BioMimetic Therapeutics BioMimetic Therapeutics, Inc. is developing and commercializing bio-active drug-device combination products for the healing of musculoskeletal injuries and disease, including periodontal, orthopedic, spine and sports injury applications. BioMimetic received marketing approval from the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. for its first product, GEM 21S([R]), as a grafting material for bone and periodontal regeneration following completion of human clinical trials, which demonstrated the safety and efficacy of its platform technology in this indication. Additionally, the Company has clinical trials ongoing for multiple orthopedic bone healing indications. The Company's product and product candidates all combine recombinant protein therapeutics with tissue specific scaffolds to actively stimulate tissue healing and regeneration. For further information, visit www.biomimetics.com or contact Kearstin Patterson, manager corporate communications, at 615-236-4419. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion